237 related articles for article (PubMed ID: 24882578)
1. Receptor-type protein tyrosine phosphatase κ directly dephosphorylates CD133 and regulates downstream AKT activation.
Shimozato O; Waraya M; Nakashima K; Souda H; Takiguchi N; Yamamoto H; Takenobu H; Uehara H; Ikeda E; Matsushita S; Kubo N; Nakagawara A; Ozaki T; Kamijo T
Oncogene; 2015 Apr; 34(15):1949-60. PubMed ID: 24882578
[TBL] [Abstract][Full Text] [Related]
2. PTPRK suppresses progression and chemo-resistance of colon cancer cells via direct inhibition of pro-oncogenic CD133.
Matsushita M; Mori Y; Uchiumi K; Ogata T; Nakamura M; Yoda H; Soda H; Takiguchi N; Nabeya Y; Shimozato O; Ozaki T
FEBS Open Bio; 2019 May; 9(5):935-946. PubMed ID: 30947381
[TBL] [Abstract][Full Text] [Related]
3. Polarized cell migration induces cancer type-specific CD133/integrin/Src/Akt/GSK3β/β-catenin signaling required for maintenance of cancer stem cell properties.
Su YJ; Lin WH; Chang YW; Wei KC; Liang CL; Chen SC; Lee JL
Oncotarget; 2015 Nov; 6(35):38029-45. PubMed ID: 26515729
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of cancer stem cell markers CD133, CD44, CD24: association with AKT isoforms and radiation resistance in colon cancer cells.
Sahlberg SH; Spiegelberg D; Glimelius B; Stenerlöw B; Nestor M
PLoS One; 2014; 9(4):e94621. PubMed ID: 24760019
[TBL] [Abstract][Full Text] [Related]
5. Activation of PI3K/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells.
Wei Y; Jiang Y; Zou F; Liu Y; Wang S; Xu N; Xu W; Cui C; Xing Y; Liu Y; Cao B; Liu C; Wu G; Ao H; Zhang X; Jiang J
Proc Natl Acad Sci U S A; 2013 Apr; 110(17):6829-34. PubMed ID: 23569237
[TBL] [Abstract][Full Text] [Related]
6. CD133+CD44+ population efficiently enriches colon cancer initiating cells.
Haraguchi N; Ohkuma M; Sakashita H; Matsuzaki S; Tanaka F; Mimori K; Kamohara Y; Inoue H; Mori M
Ann Surg Oncol; 2008 Oct; 15(10):2927-33. PubMed ID: 18663533
[TBL] [Abstract][Full Text] [Related]
7. FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function.
Song IS; Jeong YJ; Jeong SH; Heo HJ; Kim HK; Bae KB; Park YH; Kim SU; Kim JM; Kim N; Ko KS; Rhee BD; Han J
Gastroenterology; 2015 Oct; 149(4):1006-16.e9. PubMed ID: 26091938
[TBL] [Abstract][Full Text] [Related]
8. Highly enriched CD133(+)CD44(+) stem-like cells with CD133(+)CD44(high) metastatic subset in HCT116 colon cancer cells.
Chen KL; Pan F; Jiang H; Chen JF; Pei L; Xie FW; Liang HJ
Clin Exp Metastasis; 2011 Dec; 28(8):751-63. PubMed ID: 21750907
[TBL] [Abstract][Full Text] [Related]
9. NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts.
Fan X; Khaki L; Zhu TS; Soules ME; Talsma CE; Gul N; Koh C; Zhang J; Li YM; Maciaczyk J; Nikkhah G; Dimeco F; Piccirillo S; Vescovi AL; Eberhart CG
Stem Cells; 2010 Jan; 28(1):5-16. PubMed ID: 19904829
[TBL] [Abstract][Full Text] [Related]
10. Dual roles of protein tyrosine phosphatase kappa in coordinating angiogenesis induced by pro-angiogenic factors.
Sun PH; Chen G; Mason M; Jiang WG; Ye L
Int J Oncol; 2017 Apr; 50(4):1127-1135. PubMed ID: 28259897
[TBL] [Abstract][Full Text] [Related]
11. CD49f-positive cell population efficiently enriches colon cancer-initiating cells.
Haraguchi N; Ishii H; Mimori K; Ohta K; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Yamamoto H; Doki Y; Mori M
Int J Oncol; 2013 Aug; 43(2):425-30. PubMed ID: 23708747
[TBL] [Abstract][Full Text] [Related]
12. Girdin maintains the stemness of glioblastoma stem cells.
Natsume A; Kato T; Kinjo S; Enomoto A; Toda H; Shimato S; Ohka F; Motomura K; Kondo Y; Miyata T; Takahashi M; Wakabayashi T
Oncogene; 2012 May; 31(22):2715-24. PubMed ID: 22020337
[TBL] [Abstract][Full Text] [Related]
13. 8-bromo-7-methoxychrysin inhibits properties of liver cancer stem cells via downregulation of β-catenin.
Quan MF; Xiao LH; Liu ZH; Guo H; Ren KQ; Liu F; Cao JG; Deng XY
World J Gastroenterol; 2013; 19(43):7680-95. PubMed ID: 24431896
[TBL] [Abstract][Full Text] [Related]
14. Silibinin suppresses the maintenance of colorectal cancer stem-like cells by inhibiting PP2A/AKT/mTOR pathways.
Wang JY; Chang CC; Chiang CC; Chen WM; Hung SC
J Cell Biochem; 2012 May; 113(5):1733-43. PubMed ID: 22213051
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of CREB binding protein-beta-catenin signaling down regulates CD133 expression and activates PP2A-PTEN signaling in tumor initiating liver cancer cells.
Tang Y; Berlind J; Mavila N
Cell Commun Signal; 2018 Mar; 16(1):9. PubMed ID: 29530069
[TBL] [Abstract][Full Text] [Related]
16. Protein cross-talk in CD133+ colon cancer cells indicates activation of the Wnt pathway and upregulation of SRp20 that is potentially involved in tumorigenicity.
Corbo C; Orrù S; Gemei M; Noto RD; Mirabelli P; Imperlini E; Ruoppolo M; Vecchio LD; Salvatore F
Proteomics; 2012 Jun; 12(12):2045-59. PubMed ID: 22623141
[TBL] [Abstract][Full Text] [Related]
17. STAT3 is necessary for proliferation and survival in colon cancer-initiating cells.
Lin L; Liu A; Peng Z; Lin HJ; Li PK; Li C; Lin J
Cancer Res; 2011 Dec; 71(23):7226-37. PubMed ID: 21900397
[TBL] [Abstract][Full Text] [Related]
18. Regulation of CD133 by HDAC6 promotes β-catenin signaling to suppress cancer cell differentiation.
Mak AB; Nixon AM; Kittanakom S; Stewart JM; Chen GI; Curak J; Gingras AC; Mazitschek R; Neel BG; Stagljar I; Moffat J
Cell Rep; 2012 Oct; 2(4):951-63. PubMed ID: 23084749
[TBL] [Abstract][Full Text] [Related]
19. CD133(+)CXCR4(+) colon cancer cells exhibit metastatic potential and predict poor prognosis of patients.
Zhang SS; Han ZP; Jing YY; Tao SF; Li TJ; Wang H; Wang Y; Li R; Yang Y; Zhao X; Xu XD; Yu ED; Rui YC; Liu HJ; Zhang L; Wei LX
BMC Med; 2012 Aug; 10():85. PubMed ID: 22871210
[TBL] [Abstract][Full Text] [Related]
20. Receptor-type tyrosine-protein phosphatase κ directly targets STAT3 activation for tumor suppression in nasal NK/T-cell lymphoma.
Chen YW; Guo T; Shen L; Wong KY; Tao Q; Choi WW; Au-Yeung RK; Chan YP; Wong ML; Tang JC; Liu WP; Li GD; Shimizu N; Loong F; Tse E; Kwong YL; Srivastava G
Blood; 2015 Mar; 125(10):1589-600. PubMed ID: 25612622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
